Tris Pharma
Diana Ibongo has held various financial roles in different companies, including Tris Pharma, Alvogen, Corn Products Kenya Limited, National Starch LLC, ConvaTec, and Bristol-Myers Squibb. Responsible for accurate net sales reporting, GTN reporting, and liaising with upper management for shutdown processes. Led month-end close processes, budget development, and forecasting. Graduated from Rutgers University with a degree in Finance and a minor in Economics.
Tris Pharma
1 followers
Tris Pharma, Inc. is one of the top five privately-owned specialty pharmaceutical companies in the U.S. with a focus on the development of pharmaceutical science and technology-based products. Specifically, we are engaged in research, development, manufacturing, and commercialization of both branded products and specialty generic products. We have more than a dozen solid and liquid products in the U.S. market based on our numerous NDAs and ANDAs and a rich and growing portfolio of more than 30 U.S. granted patents. Our commercialization success is driven by internal resources for our pediatric products and by licensing of our non-pediatric products to other companies.